A. F. M. Motiur Rahman - Search Results

Year	Number of Results
2012	1
2013	2
2014	5
2015	1
2016	3
2017	3
2019	1
2020	4
2021	1
2022	2
2023	3
2024	0

1

Rahman AF, Korashy HM, Kassem MG. Rahman AF, et al. Profiles Drug Subst Excip Relat Methodol. 2014;39:239-64. doi: 10.1016/B978-0-12-800173-8.00005-2. Profiles Drug Subst Excip Relat Methodol. 2014. PMID: 24794908 Review.

2

Dasatinib.

Korashy HM, Rahman AF, Kassem MG. Korashy HM, et al. Among authors: rahman af. Profiles Drug Subst Excip Relat Methodol. 2014;39:205-37. doi: 10.1016/B978-0-12-800173-8.00004-0. Profiles Drug Subst Excip Relat Methodol. 2014. PMID: 24794907 Review.

3

Vardenafil dihydrochloride.

Ashour AE, Rahman AF, Kassem MG. Ashour AE, et al. Among authors: rahman af. Profiles Drug Subst Excip Relat Methodol. 2014;39:515-44. doi: 10.1016/B978-0-12-800173-8.00009-X. Profiles Drug Subst Excip Relat Methodol. 2014. PMID: 24794912 Review.

4

Editorial: Small organic molecules with anticancer activity.

Rahman AFMM, Alam MS, Kwon Y. Rahman AFMM, et al. Front Chem. 2023 Aug 23;11:1254312. doi: 10.3389/fchem.2023.1254312. eCollection 2023. Front Chem. 2023. PMID: 37681208 Free PMC article. No abstract available.

5

Synthesis and SARs study of novel spiro-oxindoles as potent antiproliferative agents with CDK-2 inhibitory activities.

Al-Jassas RM, Islam MS, Al-Majid AM, Nafie MS, Haukka M, Rahman AFMM, Alayyaf AMA, Barakat A. Al-Jassas RM, et al. Among authors: rahman afmm. Arch Pharm (Weinheim). 2023 Aug;356(8):e2300185. doi: 10.1002/ardp.202300185. Epub 2023 May 30. Arch Pharm (Weinheim). 2023. PMID: 37253118

6

Discovery of New Pyrrolo[2,3-d]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers.

Alotaibi AA, Alanazi MM, Rahman AFMM. Alotaibi AA, et al. Among authors: rahman afmm. Pharmaceuticals (Basel). 2023 Sep 19;16(9):1324. doi: 10.3390/ph16091324. Pharmaceuticals (Basel). 2023. PMID: 37765132 Free PMC article.

7

A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor.

Al-Salem HS, Arifuzzaman M, Alkahtani HM, Abdalla AN, Issa IS, Alqathama A, Albalawi FS, Rahman AFMM. Al-Salem HS, et al. Among authors: rahman afmm. Molecules. 2020 Sep 25;25(19):4400. doi: 10.3390/molecules25194400. Molecules. 2020. PMID: 32992673 Free PMC article.

8

Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.

Lu Y, Yin W, Alam MS, Kadi AA, Jahng Y, Kwon Y, Rahman AFMM. Lu Y, et al. Among authors: rahman afmm. Anticancer Agents Med Chem. 2020;20(4):464-475. doi: 10.2174/1871520619666191125130237. Anticancer Agents Med Chem. 2020. PMID: 31763968

9

Detection and characterization of simvastatin and its metabolites in rat tissues and biological fluids using MALDI high resolution mass spectrometry approach.

Yin W, Al-Wabli RI, Attwa MW, Rahman AFMM, Kadi AA. Yin W, et al. Among authors: rahman afmm. Sci Rep. 2022 Mar 19;12(1):4757. doi: 10.1038/s41598-022-08804-x. Sci Rep. 2022. PMID: 35306510 Free PMC article.

10

In Vitro Identification of Potential Metabolites of Plinabulin (NPI 2358) in Hepatic Preparations Using Liquid Chromatography-Ion Trap Mass Spectrometry.

Al-Shakliah NS, Kadi AA, Al-Salahi R, Rahman AFMM. Al-Shakliah NS, et al. Among authors: rahman afmm. ACS Omega. 2022 Jun 14;7(25):21465-21472. doi: 10.1021/acsomega.2c00929. eCollection 2022 Jun 28. ACS Omega. 2022. PMID: 35785266 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year